Career Enhancement Program
职业提升计划
基本信息
- 批准号:10208812
- 负责人:
- 金额:$ 8.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-16 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdvocacyAmerican Association of Cancer ResearchAmerican Society of Clinical OncologyAwardBioinformaticsBiologyBiometryBudgetsCancer CenterCancer Research ProjectClinicalClinical ResearchCommunitiesDiagnosisDisciplineDiseaseEarly DiagnosisFacultyFundingGoalsGovernmentGrantIndustryInstitutionLaboratoriesLaboratory ResearchLeadershipMalignant NeoplasmsMedical centerMentorsMentorshipMinorityMonitorMorbidity - disease ratePeer ReviewPersonsPreventionPrevention approachProgress ReportsPublicationsPublishingReportingResearchResearch PersonnelResearch Project GrantsResearch ProposalsResourcesScienceSocietiesTexasTranslational ResearchUniversity of Texas M D Anderson Cancer CenterWomanWritingbasecareercareer developmentclinical caredesignexperienceimprovedinnovationinterestinvestigator trainingmeetingsmelanomamembermortalitynovelprogramsprotocol developmentrecruitsuccesssymposiumtranslational scientist
项目摘要
Career Enhancement Program: Project Summary/Abstract
The goal of the Career Enhancement Program (CEP) is to use the translational research resources at the
MD Anderson Cancer Center (MDACC) to solicit and award faculty-level investigators interested in intensive
career development in the field of melanoma research to improve melanoma early detection, prevention,
and treatment. Experienced mentors serve to assist CEP awardees to develop their careers as melanoma
experts, with the goal to reduce the morbidity and mortality from this disease. The CEP will support up to
three one-year awards of $50,000 annually, with a second-year renewal based on acceptable progress.
Funds for the CEP include an annual $50,000 from the SPORE throughout the duration of the overall award,
as well as up to $100,000 per year in institutional “matching funds” from MDACC. Candidates will include the
most promising faculty-level investigators from our institution as well as from the entire Texas Medical
Center, and other SPOREs, with which we interact. The selection of CEP awardees will be based on the
scientific uniqueness, quality, and novelty of the research proposal and the appropriateness of the mentoring
plan, which will be evaluated and scored by our Internal and External Advisory Boards (IAB; EAB). The
awardees will meet with their designated mentors regularly and with CEP leadership at least monthly, and
are expected to participate in and report their progress at monthly SPORE investigator meetings and annual
IAB/EAB meetings. The CEP is led by Dr. Elizabeth Grimm for mentees with laboratory-based projects and
Dr. Jeffrey E. Lee for mentees with clinical projects; both will be involved to mentor translational researchers.
职业增强计划:项目摘要/摘要
职业增强计划(CEP)的目标是使用转化研究资源
MD Anderson癌症中心(MDACC)征求并授予教职员工级的调查员
黑色素瘤研究领域的职业发展,以改善黑色素瘤早期发现,预防,
和治疗。经验丰富的导师有助于协助CEP获奖者作为黑色素瘤的职业发展
专家,旨在降低这种疾病的发病率和死亡率。 CEP将支持
每年三年的一年奖项为50,000美元,基于可接受的进度,续期续期。
CEP的资金包括在整个奖励的整个过程中,每年的孢子中的每年50,000美元,
MDACC的机构“匹配资金”每年最高可达100,000美元。候选人将包括
我们机构以及整个德克萨斯州医学的最有前途的教师级调查员
中心和其他孢子,我们与之相互作用。 CEP奖项的选择将基于
研究建议的科学独特性,质量和新颖性以及心理的适当性
计划将由我们的内部和外部咨询委员会(IAB; EAB)评估和评分。
获奖者将定期与指定导师会面,至少每月一次与CEP领导会议,以及
预计将参加并报告他们在每月孢子调查员会议和年度
IAB/EAB会议。 CEP由伊丽莎白·格林博士(Elizabeth Grimm)领导,由实验室项目和
Jeffrey E. Lee博士的临床项目导师;两者都将参与指导翻译研究人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELIZABETH A GRIMM其他文献
ELIZABETH A GRIMM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELIZABETH A GRIMM', 18)}}的其他基金
UT M.D. Anderson Cancer Center SPORE in Melanoma
UT M.D. 安德森癌症中心黑色素瘤孢子
- 批准号:
7912014 - 财政年份:2009
- 资助金额:
$ 8.94万 - 项目类别:
PROGNOSTIC SIGNIFICANCE AND ANALYSIS OF iNOS IN MELANOMA
黑色素瘤中 iNOS 的预后意义和分析
- 批准号:
6993428 - 财政年份:2004
- 资助金额:
$ 8.94万 - 项目类别:
UT M.D. Anderson Cancer Center SPORE in Melanoma
UT M.D. 安德森癌症中心黑色素瘤孢子
- 批准号:
6949451 - 财政年份:2004
- 资助金额:
$ 8.94万 - 项目类别:
相似国自然基金
基于倡导促动理论的老年人多重慢病健康管理策略研究:理论模型、行为模式与管理路径
- 批准号:71874104
- 批准年份:2018
- 资助金额:50.0 万元
- 项目类别:面上项目
相似海外基金
Enhancing Diversity and Addressing Disparities at the 7th Cancer Cachexia Conference
第七届癌症恶病质会议增强多样性并解决差异
- 批准号:
10827795 - 财政年份:2023
- 资助金额:
$ 8.94万 - 项目类别:
Harvard Education Program in Cancer Prevention Control (R25T)
哈佛大学癌症预防控制教育计划 (R25T)
- 批准号:
7280925 - 财政年份:1992
- 资助金额:
$ 8.94万 - 项目类别: